 AUSTIN, Texas, July 21, 2021 PRNewswire -- Natera, Inc. Nasdaq: NTRA, a pioneer and global leader in cell-free DNA testing, today announced the pricing of its underwritten public offering of 4,500,000 shares of its common stock at a price to the public of 113.00 per share. Closing of the offering is expected to occur on July 26, 2021, subject to customary closing conditions. 